Related references
Note: Only part of the references are listed.A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
SARS-CoV-2: What do we know so far?
Pratik H. Khedkar et al.
ACTA PHYSIOLOGICA (2020)
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
Venkata Raveendra Pothineni et al.
SCIENTIFIC REPORTS (2020)
Remdesivir as a possible therapeutic option for the COVID-19
Jaffar A. Al-Tawfiq et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms
Bodee Nutho et al.
BIOCHEMISTRY (2020)
COVID-19: a new challenge for human beings
Penghui Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
Junmei Wang
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Race to find COVID-19 treatments accelerates
Kai Kupferschmidt et al.
SCIENCE (2020)
Naldemedine: A New Option for OIBD
Flaminia Coluzzi et al.
JOURNAL OF PAIN RESEARCH (2020)
Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds
Anh-Tien Ton et al.
MOLECULAR INFORMATICS (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus
Deng-hai Zhang et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2020)
Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
Beste Turanli et al.
EBIOMEDICINE (2019)
Chemistry, pharmacology and analysis of Pseudostellaria heterophylla: a mini-review
De-jun Hu et al.
CHINESE MEDICINE (2019)
Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus dsp1 and asp23
Elaine M. Barros et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
Andres Pizzorno et al.
FRONTIERS IN IMMUNOLOGY (2019)
Drug repurposing approaches to fight Dengue virus infection and related diseases
Lorenzo Botta et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Emerging and re-emerging infectious disease in otorhinolaryngology
F. Scasso et al.
ACTA OTORHINOLARYNGOLOGICA ITALICA (2018)
Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
Kazuya Fukumura et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
Drug repurposing from the perspective of pharmaceutical companies
Y. Cha et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Timelines of translational science: From technology initiation to FDA approval
Laura M. McNamee et al.
PLOS ONE (2017)
Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis
Sergey A. Shiryaev et al.
SCIENTIFIC REPORTS (2017)
Natural Products as Sources of New Drugs from 1981 to 2014
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2016)
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
Tomonari Muramatsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity
Imir G. Metushi et al.
PLOS ONE (2015)
MM/GBSA Binding Energy Prediction on the PDBbind Data Set: Successes, Failures, and Directions for Further Improvement
Paulette A. Greenidge et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
Calvin Yu-Chian Chen
PLOS ONE (2011)
Similarity searching
Dagmar Stumpfe et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2011)
Extended-Connectivity Fingerprints
David Rogers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
The PubChem chemical structure sketcher
Wolf D. Ihlenfeldt et al.
JOURNAL OF CHEMINFORMATICS (2009)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Reoptimization of MDL keys for use in drug discovery
JL Durant et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2002)
Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K
P Mark et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2001)
Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models
PA Kollman et al.
ACCOUNTS OF CHEMICAL RESEARCH (2000)
Share Paper
